West Coast Metabolomics Center for Compound Identification
西海岸化合物鉴定代谢组学中心
基本信息
- 批准号:9767141
- 负责人:
- 金额:$ 88.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAminesBenchmarkingBiochemical ProcessBiodiversityBiological AssayBlindedChemicalsChemistryCollaborationsCommunicationCommunitiesComputer SimulationComputer softwareComputing MethodologiesDataData ReportingDatabasesDeuteriumDiabetes MellitusDiagnosticDiseaseEnsureEnzymesFinding by CauseFundingGoalsGuidelinesHealthHybridsHydrogenIsomerismLeadershipLibrariesLinkLiteratureMachine LearningMalignant NeoplasmsMass ChromatographyMass FragmentographyMass Spectrum AnalysisMedicalMetabolismMetadataMethodsMissionModelingMolecularMonitorNorth AmericaObesityPhenotypePoliciesProcessProtocols documentationReactionReference StandardsResearch DesignResolutionResourcesSoftware ToolsSolventsStandardizationStructureTestingTimeTrainingUnited States National Institutes of HealthValidationVendorVertebral columnbasechemical standardcheminformaticscomputing resourcesdata acquisitiondata warehousedatabase designdeep learningheuristicsimprovedinnovationinsightmembermetabolomicsmodel buildingmolecular dynamicsnovelorganizational structurepredictive modelingquantum chemistryrepositorysmall moleculetooltraining opportunityworking group
项目摘要
Project Summary – Overall
West Coast Metabolomics Center for Compound Identification (WCMC)
The West Coast Metabolomics Center for Compound Identification (WCMC) is committed to the overall goals of
the NIH Common Fund Metabolomics Initiative and specifically aims to largely improve small molecule
identifications. Understanding metabolism is important to gain insight into biochemical processes and relevant
to battle diseases such as cancer, obesity and diabetes. Compound identification in metabolomics is still a
daunting task with many unknown compounds and false positive identifications. The major goal of the WCMC is
therefore to develop processes and resources that accelerate and improve the accuracy of the compound
identification workflow for experts and medical professionals. The WCMC for Compound Identification is
structured in three different entities: the Administrative Core, the Computational Core and the Experimental Core.
The Center is led by the Director Prof. Fiehn in close collaboration with quantum chemistry experts Prof. Wang
and Prof. Tantillo, and metabolomics experts Dr. Barupal and Dr. Kind with broad support from mass
spectrometry, computational metabolomics and programming experts. The Administrative Core will assist the
Computational and Experimental Core to develop and validate large in-silico mass spectral libraries, retention
time prediction models and innovative methods for constraining and ranking lists of isomers in an integrated
process of cheminformatics tools and databases. The developed tools and databases will be made available to
all Common Fund Metabolomics Consortium (CF-MC) members and professional working groups. The WCMC
will also provide guidance for compound identification to the National Metabolomics Data Repository. The broad
dissemination of developed compound identification protocols, training for compound identification workflows,
databases and distribution of internal reference standard kits for metabolomic standardization will overall widely
support the metabolomics community.
项目摘要 - 总体
西海岸复合识别代谢组学中心(WCMC)
西海岸代谢组学中心(WCMC)致力于实现的总体目标
NIH共同基金代谢组学倡议,特别是旨在在很大程度上改善小分子
标识。了解新陈代谢对于了解生化过程和相关性很重要
与癌症,肥胖和糖尿病等疾病作斗争。代谢组学中的复合鉴定仍然是
具有许多未知化合物和假阳性标识的艰巨任务。 WCMC的主要目标是
因此,开发加速和提高化合物准确性的流程和资源
专家和医疗专业人员的识别工作流程。用于化合物识别的WCMC是
在三个不同的实体中结构:管理核心,计算核心和实验核心。
该中心由董事Fiehn教授与量子化学专家Wang教授密切合作。
Tantillo教授,代谢组学专家Barupal博士和Barupal博士和Kind博士,并得到了广泛的支持
光谱,计算代谢组学和编程专家。行政核心将协助
计算和实验性核心,以发展和验证大型内部质谱库,保留率
时间预测模型和创新方法,用于限制和排名在集成中的异构体列表
化学信息学工具和数据库的过程。开发的工具和数据库将可用
所有普通基金代谢组学联盟(CF-MC)成员和专业工作组。 WCMC
还将为国家代谢组学数据存储库的复合识别提供指导。宽阔
传播开发的复合识别方案,复合识别工作流程的培训,
数据库和代谢组标准化的内部参考标准套件的分布总体上将广泛
支持代谢组学社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Oliver Fiehn其他文献
Oliver Fiehn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Oliver Fiehn', 18)}}的其他基金
Integrating metagenomics data into accurate mass stool metabolite identifications
将宏基因组数据整合到准确的粪便代谢物鉴定中
- 批准号:
10576770 - 财政年份:2022
- 资助金额:
$ 88.67万 - 项目类别:
West Coast Metabolomics Center for Compound Identification
西海岸化合物鉴定代谢组学中心
- 批准号:
10258317 - 财政年份:2018
- 资助金额:
$ 88.67万 - 项目类别:
West Coast Metabolomics Center for Compound Identification
西海岸化合物鉴定代谢组学中心
- 批准号:
10216259 - 财政年份:2018
- 资助金额:
$ 88.67万 - 项目类别:
West Coast Metabolomics Center for Compound Identification
西海岸化合物鉴定代谢组学中心
- 批准号:
10012976 - 财政年份:2018
- 资助金额:
$ 88.67万 - 项目类别:
Novel Metabolic Predictors of Diabetes in American Indians
美洲印第安人糖尿病的新代谢预测因子
- 批准号:
9351506 - 财政年份:2016
- 资助金额:
$ 88.67万 - 项目类别:
Novel Metabolic Predictors of Diabetes in American Indians
美洲印第安人糖尿病的新代谢预测因子
- 批准号:
9176506 - 财政年份:2016
- 资助金额:
$ 88.67万 - 项目类别:
相似国自然基金
柑橘意大利青霉咪鲜胺抗性菌株耐药性形成机制研究
- 批准号:32372396
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
烟曲链霉菌不对称合成手性胺类人工产物4β-AIP的手性控制机制
- 批准号:22378230
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
叔胺调控无水复合胺相变吸收CO2机理及传质-反应动力学研究
- 批准号:22366012
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
磷脂酰乙醇胺代谢紊乱介导自噬相关磷酸化α-syn清除异常在术后认知恢复延迟中作用及机制
- 批准号:82301359
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
StSAMDC调控多胺参与马铃薯晚疫病抗性的机制研究
- 批准号:32301848
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Intracellular RNA Nanoparticle Therapeutics to Treat Retinal Neovascularization
细胞内 RNA 纳米颗粒治疗视网膜新生血管
- 批准号:
10717749 - 财政年份:2023
- 资助金额:
$ 88.67万 - 项目类别:
Probing the rules of molecular recognition through the de novo design of proteins that bind small-molecule drugs.
通过从头设计结合小分子药物的蛋白质来探索分子识别的规则。
- 批准号:
10463468 - 财政年份:2022
- 资助金额:
$ 88.67万 - 项目类别:
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
通过基于多抗原 RNA 的疫苗快速应对大流行性流感
- 批准号:
10491533 - 财政年份:2022
- 资助金额:
$ 88.67万 - 项目类别: